Free tool
Stocks above their 200-day average
We cover 4 companies trading above their own 200-day average. The median market value in the group is $140.50M. Across the group, the median move over the past trading day is −10.30%. Price change over the past year runs from +13.6% to +216.1% across the middle 80 percent of the group, with a median of +35.2%.
Other lists in this group
Table
4 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| N1BI34.SA | Neurocrine Biosciences, Inc. | 39.64 BRL | −10.88% | −1.69% | +7.37% |
| ELMD | Electromed, Inc. | $31.77 | −19.53% | +15.99% | +28.26% |
| ORTI-B.ST | Ortivus AB (publ) | 1.62 SEK | −13.83% | +32.79% | +42.11% |
| SILO | Silo Pharma, Inc. | $2.50 | −43.95% | +644.05% | +290.62% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.